Your browser doesn't support javascript.
loading
Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-α-accelerated lupus nephritis in mice.
Chen, Kuan-Ju; Zhang, Jimin; LaSala, Daniel; Basso, Jessica; Chun, Donald; Zhou, Yuchen; McDonald, Patrick P; Perkins, Walter R; Cipolla, David C.
Afiliação
  • Chen KJ; Research Department of Insmed Incorporated, Bridgewater, NJ, United States.
  • Zhang J; Research Department of Insmed Incorporated, Bridgewater, NJ, United States.
  • LaSala D; Research Department of Insmed Incorporated, Bridgewater, NJ, United States.
  • Basso J; Research Department of Insmed Incorporated, Bridgewater, NJ, United States.
  • Chun D; Research Department of Insmed Incorporated, Bridgewater, NJ, United States.
  • Zhou Y; Research Department of Insmed Incorporated, Bridgewater, NJ, United States.
  • McDonald PP; Research Department of Insmed Incorporated, Bridgewater, NJ, United States.
  • Perkins WR; Research Department of Insmed Incorporated, Bridgewater, NJ, United States.
  • Cipolla DC; Research Department of Insmed Incorporated, Bridgewater, NJ, United States.
Front Immunol ; 14: 1185727, 2023.
Article em En | MEDLINE | ID: mdl-37441081
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nefrite Lúpica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nefrite Lúpica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article